{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:13:52Z","timestamp":1787170432830,"version":"build-2736575974"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["26343"],"award-info":[{"award-number":["26343"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Cariverona: Oncology Biobank Project 'Antonio Schiavi'","award":["203885\/2017"],"award-info":[{"award-number":["203885\/2017"]}]},{"DOI":"10.13039\/100020349","name":"Fondazione Italiana per la ricerca sulle Malattie del Pancreas","doi-asserted-by":"publisher","award":["FIMP-J38D19000690001"],"award-info":[{"award-number":["FIMP-J38D19000690001"]}],"id":[{"id":"10.13039\/100020349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019\u2010105201RB\u2010I00"],"award-info":[{"award-number":["PID2019\u2010105201RB\u2010I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s12022-026-09923-1","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:09:04Z","timestamp":1783573744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Integrative RNA Spliceosomic Landscape of Pancreatic Neuroendocrine Tumors Identifies Clinically Relevant Molecular Subgroups"],"prefix":"10.1007","volume":"37","author":[{"given":"Ricardo","family":"Bl\u00e1zquez-Encinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"Garc\u00eda-Vioque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mafficini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ruiz-Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Guti\u00e9rrez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Trinidad","family":"Moreno-Montilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Alcala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Eyras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Paiella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Rovite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Foll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynnette","family":"Fernandez-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita T.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-0095","authenticated-orcid":false,"given":"Alejandro","family":"Ib\u00e1\u00f1ez-Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8371-6589","authenticated-orcid":false,"given":"Sergio","family":"Pedraza-Arevalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3145-7287","authenticated-orcid":false,"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"9923_CR1","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O (2023) RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer 23:135\u2013155. https:\/\/doi.org\/10.1038\/s41568-022-00541-7","journal-title":"Nat Rev Cancer"},{"key":"9923_CR2","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC-W Lee","year":"2016","unstructured":"Lee SC-W, Abdel-Wahab O (2016) Therapeutic targeting of splicing in cancer. Nat Med 22:976\u2013986. https:\/\/doi.org\/10.1038\/nm.4165","journal-title":"Nat Med"},{"key":"9923_CR3","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","volume":"17","author":"SC Bonnal","year":"2020","unstructured":"Bonnal SC, L\u00f3pez-Oreja I, Valc\u00e1rcel J (2020) Roles and mechanisms of alternative splicing in cancer - implications for care. Nat Rev Clin Oncol 17:457\u2013474. https:\/\/doi.org\/10.1038\/s41571-020-0350-x","journal-title":"Nat Rev Clin Oncol"},{"key":"9923_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-cancerbio-030617-050407","volume":"3","author":"L Escobar-Hoyos","year":"2019","unstructured":"Escobar-Hoyos L, Knorr K, Abdel-Wahab O (2019) Aberrant RNA Splicing in Cancer. Annu Rev Cancer Biol 3:167\u2013185. https:\/\/doi.org\/10.1146\/annurev-cancerbio-030617-050407","journal-title":"Annu Rev Cancer Biol"},{"key":"9923_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/21541264.2016.1268245","volume":"8","author":"B Singh","year":"2017","unstructured":"Singh B, Eyras E (2017) The role of alternative splicing in cancer. Transcription 8:91\u201398. https:\/\/doi.org\/10.1080\/21541264.2016.1268245","journal-title":"Transcription"},{"key":"9923_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1101\/gr.199935.115","volume":"26","author":"E Sebesty\u00e9n","year":"2016","unstructured":"Sebesty\u00e9n E, Singh B, Mi\u00f1ana B, Pag\u00e8s A, Mateo F, Pujana MA, Valc\u00e1rcel J, Eyras E (2016) Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks. Genome Res 26:732\u2013744. https:\/\/doi.org\/10.1101\/gr.199935.115","journal-title":"Genome Res"},{"key":"9923_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2018.07.001","volume":"34","author":"A Kahles","year":"2018","unstructured":"Kahles A, Lehmann K-V, Toussaint NC, H\u00fcser M, Stark SG, Sachsenberg T, Stegle O, Kohlbacher O, Sander C, Cancer Genome Atlas Research Network, R\u00e4tsch G (2018) Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Cancer Cell 34:211\u2013224.e6. https:\/\/doi.org\/10.1016\/j.ccell.2018.07.001","journal-title":"Cancer Cell"},{"key":"9923_CR8","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1093\/nar\/gkv210","volume":"43","author":"M Danan-Gotthold","year":"2015","unstructured":"Danan-Gotthold M, Golan-Gerstl R, Eisenberg E, Meir K, Karni R, Levanon EY (2015) Identification of recurrent regulated alternative splicing events across human solid tumors. Nucleic Acids Res 43:5130\u20135144. https:\/\/doi.org\/10.1093\/nar\/gkv210","journal-title":"Nucleic Acids Res"},{"key":"9923_CR9","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1038\/s41388-021-01947-7","volume":"40","author":"R Cheng","year":"2021","unstructured":"Cheng R, Xiao L, Zhou W, Jin X, Xu Z, Xu C, Wang P, Luo M, Wang M, Ma K, Cao H, Huang Y, Lin X, Pang F, Li Y, Jiang Q (2021) A pan-cancer analysis of alternative splicing of splicing factors in 6904 patients. Oncogene 40:5441\u20135450. https:\/\/doi.org\/10.1038\/s41388-021-01947-7","journal-title":"Oncogene"},{"key":"9923_CR10","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.celrep.2017.08.012","volume":"20","author":"H Climente-Gonz\u00e1lez","year":"2017","unstructured":"Climente-Gonz\u00e1lez H, Porta-Pardo E, Godzik A, Eyras E (2017) The Functional Impact of Alternative Splicing in Cancer. Cell Rep 20:2215\u20132226. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.012","journal-title":"Cell Rep"},{"key":"9923_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1146\/annurev-med-042320-011248","volume":"73","author":"A Chang","year":"2022","unstructured":"Chang A, Sherman SK, Howe JR, Sahai V (2022) Progress in the Management of Pancreatic Neuroendocrine Tumors. Annu Rev Med 73:213\u2013229. https:\/\/doi.org\/10.1146\/annurev-med-042320-011248","journal-title":"Annu Rev Med"},{"key":"9923_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1210\/endrev\/bnz004","volume":"41","author":"J Hofland","year":"2020","unstructured":"Hofland J, Kaltsas G, de Herder WW (2020) Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms. Endocr Rev 41:371\u2013403. https:\/\/doi.org\/10.1210\/endrev\/bnz004","journal-title":"Endocr Rev"},{"key":"9923_CR13","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/endrev\/bnad006","volume":"44","author":"R Garcia-Carbonero","year":"2023","unstructured":"Garcia-Carbonero R, Anton-Pascual B, Modrego A, Del Carmen Riesco-Martinez M, Lens-Pardo A, Carretero-Puche C, Rubio-Cuesta B, Soldevilla B (2023) Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward? Endocr Rev 44:724\u2013736. https:\/\/doi.org\/10.1210\/endrev\/bnad006","journal-title":"Endocr Rev"},{"key":"9923_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/oncolo\/oyac049","volume":"27","author":"MB Sonbol","year":"2022","unstructured":"Sonbol MB, Mazza GL, Mi L, Oliver T, Starr J, Gudmundsdottir H, Cleary SP, Hobday T, Halfdanarson TR (2022) Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis. The Oncologist 27:573\u2013578. https:\/\/doi.org\/10.1093\/oncolo\/oyac049","journal-title":"The Oncologist"},{"key":"9923_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11154-018-9465-0","volume":"19","author":"S Pedraza-Ar\u00e9valo","year":"2018","unstructured":"Pedraza-Ar\u00e9valo S, Gahete MD, Alors-P\u00e9rez E, Luque RM, Casta\u00f1o JP (2018) Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors. Rev Endocr Metab Disord 19:179\u2013192. https:\/\/doi.org\/10.1007\/s11154-018-9465-0","journal-title":"Rev Endocr Metab Disord"},{"key":"9923_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1210\/er.2018-00160","volume":"40","author":"A Mafficini","year":"2019","unstructured":"Mafficini A, Scarpa A (2019) Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Rev 40:506\u2013536. https:\/\/doi.org\/10.1210\/er.2018-00160","journal-title":"Endocr Rev"},{"key":"9923_CR17","doi-asserted-by":"publisher","first-page":"e13318","DOI":"10.1111\/jne.13318","volume":"35","author":"J Hofland","year":"2023","unstructured":"Hofland J, Falconi M, Christ E, Casta\u00f1o JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad V, Ruszniewski P, Thirlwell C, Vullierme M-P, Welin S, Bartsch DK (2023) European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol 35:e13318. https:\/\/doi.org\/10.1111\/jne.13318","journal-title":"J Neuroendocrinol"},{"key":"9923_CR18","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/jne.13343","volume":"35","author":"B Kos-Kud\u0142a","year":"2023","unstructured":"Kos-Kud\u0142a B, Casta\u00f1o JP, Denecke T, Grande E, Kjaer A, Koumarianou A, de Mestier L, Partelli S, Perren A, St\u00e4ttner S, Valle JW, Fazio N (2023) European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol 35:e13343. https:\/\/doi.org\/10.1111\/jne.13343","journal-title":"J Neuroendocrinol"},{"key":"9923_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington KM, Carneiro F, Cree IA, WHO Classification of Tumours Editorial Board (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182\u2013188. https:\/\/doi.org\/10.1111\/his.13975","journal-title":"Histopathology"},{"key":"9923_CR20","unstructured":"Bosman, FT, Carneiro, F, Hruban, RH, Theise, ND (2010) WHO Classification of Tumours of the Digestive System"},{"key":"9923_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature21063","volume":"543","author":"A Scarpa","year":"2017","unstructured":"Scarpa A, Chang DK, Nones K, Corbo V, Patch A-M, Bailey P, Lawlor RT, Johns AL, Miller DK, Mafficini A, Rusev B, Scardoni M, Antonello D, Barbi S, Sikora KO, Cingarlini S, Vicentini C, McKay S, Quinn MCJ, Bruxner TJC, Christ AN, Harliwong I, Idrisoglu S, McLean S, Nourse C, Nourbakhsh E, Wilson PJ, Anderson MJ, Fink JL, Newell F, Waddell N, Holmes O, Kazakoff SH, Leonard C, Wood S, Xu Q, Nagaraj SH, Amato E, Dalai I, Bersani S, Cataldo I, Dei Tos AP, Capelli P, Dav\u00ec MV, Landoni L, Malpaga A, Miotto M, Whitehall VLJ, Leggett BA, Harris JL, Harris J, Jones MD, Humphris J, Chantrill LA, Chin V, Nagrial AM, Pajic M, Scarlett CJ, Pinho A, Rooman I, Toon C, Wu J, Pinese M, Cowley M, Barbour A, Mawson A, Humphrey ES, Colvin EK, Chou A, Lovell JA, Jamieson NB, Duthie F, Gingras M-C, Fisher WE, Dagg RA, Lau LMS, Lee M, Pickett HA, Reddel RR, Samra JS, Kench JG, Merrett ND, Epari K, Nguyen NQ, Zeps N, Falconi M, Simbolo M, Butturini G, Van Buren G, Partelli S, Fassan M, Australian Pancreatic Cancer Genome Initiative, Khanna KK, Gill AJ, Wheeler DA, Gibbs RA, Musgrove EA, Bassi C, Tortora G, Pederzoli P, Pearson JV, Waddell N, Biankin AV, Grimmond SM (2017) Whole-genome landscape of pancreatic neuroendocrine tumours. Nature 543:65\u201371. https:\/\/doi.org\/10.1038\/nature21063","journal-title":"Nature"},{"key":"9923_CR22","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1158\/2159-8290.CD-15-0068","volume":"5","author":"A Sadanandam","year":"2015","unstructured":"Sadanandam A, Wullschleger S, Lyssiotis CA, Gr\u00f6tzinger C, Barbi S, Bersani S, K\u00f6rner J, Wafy I, Mafficini A, Lawlor RT, Simbolo M, Asara JM, Bl\u00e4ker H, Cantley LC, Wiedenmann B, Scarpa A, Hanahan D (2015) A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. Cancer Discov 5:1296\u20131313. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0068","journal-title":"Cancer Discov"},{"key":"9923_CR23","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1158\/1078-0432.CCR-19-2884","volume":"26","author":"AT Scott","year":"2020","unstructured":"Scott AT, Weitz M, Breheny PJ, Ear PH, Darbro B, Brown BJ, Braun TA, Li G, Umesalma S, Kaemmer CA, Maharjan CK, Quelle DE, Bellizzi AM, Chandrasekharan C, Dillon JS, O\u2019Dorisio TM, Howe JR (2020) Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Clin Cancer Res Off J Am Assoc Cancer Res 26:2011\u20132021. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-2884","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"9923_CR24","doi-asserted-by":"publisher","first-page":"109817","DOI":"10.1016\/j.celrep.2021.109817","volume":"37","author":"KC Yang","year":"2021","unstructured":"Yang KC, Kalloger SE, Aird JJ, Lee MKC, Rushton C, Mungall KL, Mungall AJ, Gao D, Chow C, Xu J, Karasinska JM, Colborne S, Jones SJM, Schrader J, Morin RD, Loree JM, Marra MA, Renouf DJ, Morin GB, Schaeffer DF, Gorski SM (2021) Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms. Cell Rep 37:109817. https:\/\/doi.org\/10.1016\/j.celrep.2021.109817","journal-title":"Cell Rep"},{"key":"9923_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s42003-020-01469-0","volume":"4","author":"V Lakis","year":"2021","unstructured":"Lakis V, Lawlor RT, Newell F, Patch A-M, Mafficini A, Sadanandam A, Koufariotis LT, Johnston RL, Leonard C, Wood S, Rusev B, Corbo V, Luchini C, Cingarlini S, Landoni L, Salvia R, Milella M, Chang D, Bailey P, Jamieson NB, Duthie F, Gingras M-C, Muzny DM, Wheeler DA, Gibbs RA, Milione M, APGI, ARC-Net, Pederzoli P, Samra JS, Gill AJ, Johns AL, Pearson JV, Biankin AV, Grimmond SM, Waddell N, Nones K, Scarpa A (2021) DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association. Commun Biol 4:155. https:\/\/doi.org\/10.1038\/s42003-020-01469-0","journal-title":"Commun Biol"},{"key":"9923_CR26","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1158\/2159-8290.CD-20-1637","volume":"11","author":"S Saghafinia","year":"2021","unstructured":"Saghafinia S, Homicsko K, Di Domenico A, Wullschleger S, Perren A, Marinoni I, Ciriello G, Michael IP, Hanahan D (2021) Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression. Cancer Discov 11:2638\u20132657. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-1637","journal-title":"Cancer Discov"},{"key":"9923_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.semcancer.2019.09.024","volume":"61","author":"K Young","year":"2020","unstructured":"Young K, Starling N, Sadanandam A (2020) The molecular biology of pancreatic neuroendocrine neoplasms: Challenges and translational opportunities. Semin Cancer Biol 61:132\u2013138. https:\/\/doi.org\/10.1016\/j.semcancer.2019.09.024","journal-title":"Semin Cancer Biol"},{"key":"9923_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12022-024-09807-2","volume":"35","author":"S Uccella","year":"2024","unstructured":"Uccella S (2024) Molecular Classification of Gastrointestinal and Pancreatic Neuroendocrine Neoplasms: Are We Ready for That? Endocr Pathol 35:91\u2013106. https:\/\/doi.org\/10.1007\/s12022-024-09807-2","journal-title":"Endocr Pathol"},{"key":"9923_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11154-022-09771-4","volume":"24","author":"R Bl\u00e1zquez-Encinas","year":"2023","unstructured":"Bl\u00e1zquez-Encinas R, Moreno-Montilla MT, Garc\u00eda-Vioque V, Gracia-Navarro F, Alors-P\u00e9rez E, Pedraza-Arevalo S, Ib\u00e1\u00f1ez-Costa A, Casta\u00f1o JP (2023) The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities. Rev Endocr Metab Disord 24:267\u2013282. https:\/\/doi.org\/10.1007\/s11154-022-09771-4","journal-title":"Rev Endocr Metab Disord"},{"key":"9923_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.trsl.2022.07.005","volume":"251","author":"S Pedraza-Arevalo","year":"2023","unstructured":"Pedraza-Arevalo S, Alors-P\u00e9rez E, Bl\u00e1zquez-Encinas R, Herrera-Mart\u00ednez AD, Jim\u00e9nez-Vacas JM, Fuentes-Fayos AC, Reyes \u00d3, Ventura S, S\u00e1nchez-S\u00e1nchez R, Ortega-Salas R, Serrano-Blanch R, G\u00e1lvez-Moreno MA, Gahete MD, Ib\u00e1\u00f1ez-Costa A, Luque RM, Casta\u00f1o JP (2023) Spliceosomic dysregulation unveils NOVA1 as a candidate actionable therapeutic target in pancreatic neuroendocrine tumors. Transl Res J Lab Clin Med 251:63\u201373. https:\/\/doi.org\/10.1016\/j.trsl.2022.07.005","journal-title":"Transl Res J Lab Clin Med"},{"key":"9923_CR31","doi-asserted-by":"publisher","first-page":"102090","DOI":"10.1016\/j.omtn.2023.102090","volume":"35","author":"E Alors-P\u00e9rez","year":"2024","unstructured":"Alors-P\u00e9rez E, Pedraza-Arevalo S, Bl\u00e1zquez-Encinas R, Garc\u00eda-Vioque V, Agraz-Doblas A, Yubero-Serrano EM, S\u00e1nchez-Fr\u00edas ME, Serrano-Blanch R, G\u00e1lvez-Moreno M\u00c1, Gracia-Navarro F, Gahete MD, Arjona-S\u00e1nchez \u00c1, Luque RM, Ib\u00e1\u00f1ez-Costa A, Casta\u00f1o JP (2024) Altered CELF4 splicing factor enhances pancreatic neuroendocrine tumors aggressiveness influencing mTOR and everolimus response. Mol Ther - Nucleic Acids 35:102090. https:\/\/doi.org\/10.1016\/j.omtn.2023.102090","journal-title":"Mol Ther - Nucleic Acids"},{"key":"9923_CR32","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s13046-023-02858-z","volume":"42","author":"E Alors-P\u00e9rez","year":"2023","unstructured":"Alors-P\u00e9rez E, Pedraza-Arevalo S, Bl\u00e1zquez-Encinas R, Moreno-Montilla MT, Garc\u00eda-Vioque V, Berbel I, Luque RM, Sainz B, Ib\u00e1\u00f1ez-Costa A, Casta\u00f1o JP (2023) Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential. J Exp Clin Cancer Res CR 42:282. https:\/\/doi.org\/10.1186\/s13046-023-02858-z","journal-title":"J Exp Clin Cancer Res CR"},{"key":"9923_CR33","doi-asserted-by":"publisher","first-page":"e62692","DOI":"10.1371\/journal.pone.0062692","volume":"8","author":"M Simbolo","year":"2013","unstructured":"Simbolo M, Gottardi M, Corbo V, Fassan M, Mafficini A, Malpeli G, Lawlor RT, Scarpa A (2013) DNA qualification workflow for next generation sequencing of histopathological samples. PloS One 8:e62692. https:\/\/doi.org\/10.1371\/journal.pone.0062692","journal-title":"PloS One"},{"key":"9923_CR34","doi-asserted-by":"publisher","first-page":"5324","DOI":"10.1016\/j.ygeno.2020.10.032","volume":"112","author":"PA Beer","year":"2020","unstructured":"Beer PA, Cooke SL, Chang DK, Biankin AV (2020) Defining the clinical genomic landscape for real-world precision oncology. Genomics 112:5324\u20135330. https:\/\/doi.org\/10.1016\/j.ygeno.2020.10.032","journal-title":"Genomics"},{"key":"9923_CR35","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinforma Oxf Engl 25:1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324","journal-title":"Bioinforma Oxf Engl"},{"key":"9923_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1751-0473-9-13","volume":"9","author":"G Tischler","year":"2014","unstructured":"Tischler G, Leonard S (2014) biobambam: tools for read pair collation based algorithms on BAM files. Source Code Biol Med 9:13. https:\/\/doi.org\/10.1186\/1751-0473-9-13","journal-title":"Source Code Biol Med"},{"key":"9923_CR37","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R, 1000 Genome Project Data Processing Subgroup (2009) The Sequence Alignment\/Map format and SAMtools. Bioinforma Oxf Engl 25:2078\u20132079. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352","journal-title":"Bioinforma Oxf Engl"},{"key":"9923_CR38","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/bioinformatics\/btt750","volume":"30","author":"M Gerstung","year":"2014","unstructured":"Gerstung M, Papaemmanuil E, Campbell PJ (2014) Subclonal variant calling with multiple samples and prior knowledge. Bioinforma Oxf Engl 30:1198\u20131204. https:\/\/doi.org\/10.1093\/bioinformatics\/btt750","journal-title":"Bioinforma Oxf Engl"},{"key":"9923_CR39","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","volume":"25","author":"K Ye","year":"2009","unstructured":"Ye K, Schulz MH, Long Q, Apweiler R, Ning Z (2009) Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinforma Oxf Engl 25:2865\u20132871. https:\/\/doi.org\/10.1093\/bioinformatics\/btp394","journal-title":"Bioinforma Oxf Engl"},{"key":"9923_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fgene.2012.00035","volume":"3","author":"P Cingolani","year":"2012","unstructured":"Cingolani P, Patel VM, Coon M, Nguyen T, Land SJ, Ruden DM, Lu X (2012) Using Drosophila melanogaster as a Model for Genotoxic Chemical Mutational Studies with a New Program, SnpSift. Front Genet 3:35. https:\/\/doi.org\/10.3389\/fgene.2012.00035","journal-title":"Front Genet"},{"key":"9923_CR41","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/bioinformatics\/btq330","volume":"26","author":"W McLaren","year":"2010","unstructured":"McLaren W, Pritchard B, Rios D, Chen Y, Flicek P, Cunningham F (2010) Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinforma Oxf Engl 26:2069\u20132070. https:\/\/doi.org\/10.1093\/bioinformatics\/btq330","journal-title":"Bioinforma Oxf Engl"},{"key":"9923_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsd\u00f3ttir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP (2011) Integrative genomics viewer. Nat Biotechnol 29:24\u201326. https:\/\/doi.org\/10.1038\/nbt.1754","journal-title":"Nat Biotechnol"},{"key":"9923_CR43","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-025-01973-6","volume":"13","author":"G Zanconato","year":"2025","unstructured":"Zanconato G, Hernandez Gamero G, Mafficini A, Pedron S, Mulone D, Alberti S, Caffo M, Barresi V (2025) Refining prognostic stratification of atypical meningiomas: significance of chromosome 1p deletion and brain invasion. Acta Neuropathol Commun 13:50. https:\/\/doi.org\/10.1186\/s40478-025-01973-6","journal-title":"Acta Neuropathol Commun"},{"key":"9923_CR44","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29:15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"9923_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W (2015) HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31:166\u2013169. https:\/\/doi.org\/10.1093\/bioinformatics\/btu638","journal-title":"Bioinformatics"},{"key":"9923_CR46","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"9923_CR47","doi-asserted-by":"publisher","unstructured":"Wang Y, Xie Z, Kutschera E, Adams JI, Kadash-Edmondson KE, Xing Y (2024) rMATS-turbo: an efficient and flexible computational tool for alternative splicing analysis of large-scale RNA-seq data. Nat Protoc 1\u201322. https:\/\/doi.org\/10.1038\/s41596-023-00944-2","DOI":"10.1038\/s41596-023-00944-2"},{"key":"9923_CR48","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1158\/0008-5472.CAN-20-1807","volume":"SU2","author":"A Paschalis","year":"2021","unstructured":"Paschalis A, Welti J, Neeb AJ, Yuan W, Figueiredo I, Pereira R, Ferreira A, Riisnaes R, Rodrigues DN, Jim\u00e9nez-Vacas JM, Kim S, Uo T, Micco PD, Tumber A, Islam MS, Moesser MA, Abboud M, Kawamura A, Gurel B, Christova R, Gil VS, Buroni L, Crespo M, Miranda S, Lambros MB, Carreira S, Tunariu N, Alimonti A, Al-Lazikani B, Schofield CJ, Plymate SR, Sharp A, de Bono JS,, SU2C\/PCF International Prostate Cancer Dream Team (2021) JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer. Cancer Res 81:1087\u20131100. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1807","journal-title":"Cancer Res"},{"key":"9923_CR49","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics 14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7","journal-title":"BMC Bioinformatics"},{"key":"9923_CR50","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G (2021) clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation 2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"The Innovation"},{"key":"9923_CR51","doi-asserted-by":"publisher","first-page":"e26476","DOI":"10.7554\/eLife.26476","volume":"6","author":"J Racle","year":"2017","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D (2017) Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. eLife 6:e26476. https:\/\/doi.org\/10.7554\/eLife.26476","journal-title":"eLife"},{"key":"9923_CR52","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1101\/gr.212696.116","volume":"27","author":"L-C Tranchevent","year":"2017","unstructured":"Tranchevent L-C, Aub\u00e9 F, Dulaurier L, Benoit-Pilven C, Rey A, Poret A, Chautard E, Mortada H, Desmet F-O, Chakrama FZ, Moreno-Garcia MA, Goillot E, Janczarski S, Mortreux F, Bourgeois CF, Auboeuf D (2017) Identification of protein features encoded by alternative exons using Exon Ontology. Genome Res 27:1087\u20131097. https:\/\/doi.org\/10.1101\/gr.212696.116","journal-title":"Genome Res"},{"key":"9923_CR53","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1093\/nar\/gkad111","volume":"51","author":"EK Flemington","year":"2023","unstructured":"Flemington EK, Flemington SA, O\u2019Grady TM, Baddoo M, Nguyen T, Dong Y, Ungerleider NA (2023) SpliceTools, a suite of downstream RNA splicing analysis tools to investigate mechanisms and impact of alternative splicing. Nucleic Acids Res 51:e42. https:\/\/doi.org\/10.1093\/nar\/gkad111","journal-title":"Nucleic Acids Res"},{"key":"9923_CR54","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","volume":"13","author":"F Rohart","year":"2017","unstructured":"Rohart F, Gautier B, Singh A, L\u00ea Cao K-A (2017) mixOmics: An R package for \u2019omics feature selection and multiple data integration. PLoS Comput Biol 13:e1005752. https:\/\/doi.org\/10.1371\/journal.pcbi.1005752","journal-title":"PLoS Comput Biol"},{"key":"9923_CR55","doi-asserted-by":"crossref","unstructured":"Bailey TL, Grant CE (2021) SEA: Simple Enrichment Analysis of motifs. 2021.08.23.457422","DOI":"10.1101\/2021.08.23.457422"},{"key":"9923_CR56","doi-asserted-by":"publisher","first-page":"W39","DOI":"10.1093\/nar\/gkv416","volume":"43","author":"TL Bailey","year":"2015","unstructured":"Bailey TL, Johnson J, Grant CE, Noble WS (2015) The MEME Suite. Nucleic Acids Res 43:W39\u2013W49. https:\/\/doi.org\/10.1093\/nar\/gkv416","journal-title":"Nucleic Acids Res"},{"key":"9923_CR57","doi-asserted-by":"publisher","first-page":"7001","DOI":"10.1245\/s10434-024-15632-y","volume":"31","author":"OC Eren","year":"2024","unstructured":"Eren OC, Bagci P, Balci S, Ohike N, Saka B, Sokmensuer C, Leblebici CB, Xue Y, Reid MD, Krasinskas AM, Kooby D, Maithel SK, Sarmiento J, Cheng JD, Taskin OC, Kapran Y, Tarcan ZC, Luchini C, Scarpa A, Basturk O, Adsay NV (2024) Subgrading of G2 Pancreatic Neuroendocrine Tumors as 2A (Ki67 3% to <\u200910%) Versus 2B (10% to \u2264\u200920%) Identifies Behaviorally Distinct Subsets in Keeping with the Evolving Management Protocols. Ann Surg Oncol 31:7001\u20137011. https:\/\/doi.org\/10.1245\/s10434-024-15632-y","journal-title":"Ann Surg Oncol"},{"key":"9923_CR58","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ccell.2025.03.016","volume":"43","author":"S Ji","year":"2025","unstructured":"Ji S, Cao L, Gao J, Du Y, Ye Z, Lou X, Liu F, Zhang Y, Xu J, Shi X, Wang H, Li P, Li Y, Chen H, Yang Z, Gao S, Zhang W, Huang D, Ni S, Wei M, Wang F, Wang Y, Ding T, Jing D, Fan G, Gong Z, Lu R, Qin Y, Chen J, Xu X, Wang P, Zhang B, Ding L, Robles AI, Rodriguez H, Chang DK, Hruban RH, Gao D, Gao D, Jin G, Zhou H, Wu J, Yu X (2025) Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups. Cancer Cell 43:776\u2013796.e14. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.016","journal-title":"Cancer Cell"},{"key":"9923_CR59","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s42003-020-01479-y","volume":"3","author":"A Di Domenico","year":"2020","unstructured":"Di Domenico A, Pipinikas CP, Maire RS, Br\u00e4utigam K, Simillion C, Dettmer MS, Vassella E, Thirlwell C, Perren A, Marinoni I (2020) Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression. Commun Biol 3:740. https:\/\/doi.org\/10.1038\/s42003-020-01479-y","journal-title":"Commun Biol"},{"key":"9923_CR60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1126\/science.aax2957","volume":"366","author":"SL Wolin","year":"2019","unstructured":"Wolin SL, Maquat LE (2019) Cellular RNA surveillance in health and disease. Science 366:822\u2013827. https:\/\/doi.org\/10.1126\/science.aax2957","journal-title":"Science"},{"key":"9923_CR61","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","volume":"71","author":"WM Hackeng","year":"2022","unstructured":"Hackeng WM, Brosens LAA, Kim JY, O\u2019Sullivan R, Sung Y-N, Liu T-C, Cao D, Heayn M, Brosnan-Cashman J, An S, Morsink FHM, Heidsma CM, Valk GD, Vriens MR, Nieveen van Dijkum E, Offerhaus GJA, Dreijerink KMA, Zeh H, Zureikat AH, Hogg M, Lee K, Geller D, Marsh JW, Paniccia A, Ongchin M, Pingpank JF, Bahary N, Aijazi M, Brand R, Chennat J, Das R, Fasanella KE, Khalid A, McGrath K, Sarkaria S, Singh H, Slivka A, Nalesnik M, Han X, Nikiforova MN, Lawlor RT, Mafficini A, Rusev B, Corbo V, Luchini C, Bersani S, Pea A, Cingarlini S, Landoni L, Salvia R, Milione M, Milella M, Scarpa A, Hong S-M, Heaphy CM, Singhi AD (2022) Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size. Gut 71:961\u2013973. https:\/\/doi.org\/10.1136\/gutjnl-2020-322595","journal-title":"Gut"},{"key":"9923_CR62","doi-asserted-by":"publisher","first-page":"49796","DOI":"10.18632\/oncotarget.17964","volume":"8","author":"JK Park","year":"2017","unstructured":"Park JK, Paik WH, Lee K, Ryu JK, Lee SH, Kim Y-T (2017) DAXX\/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors. Oncotarget 8:49796\u201349806. https:\/\/doi.org\/10.18632\/oncotarget.17964","journal-title":"Oncotarget"},{"key":"9923_CR63","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1126\/science.1207313","volume":"333","author":"CM Heaphy","year":"2011","unstructured":"Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, Bigner DD, Oba-Shinjo SM, Marie SKN, Riggins GJ, Kinzler KW, Vogelstein B, Hruban RH, Maitra A, Papadopoulos N, Meeker AK (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333:425. https:\/\/doi.org\/10.1126\/science.1207313","journal-title":"Science"},{"key":"9923_CR64","doi-asserted-by":"publisher","first-page":"11818","DOI":"10.1093\/nar\/gku861","volume":"42","author":"O Villate","year":"2014","unstructured":"Villate O, Turatsinze J-V, Mascali LG, Grieco FA, Nogueira TC, Cunha DA, Nardelli TR, Sammeth M, Salunkhe VA, Esguerra JLS, Eliasson L, Marselli L, Marchetti P, Eizirik DL (2014) Nova1 is a master regulator of alternative splicing in pancreatic beta cells. Nucleic Acids Res 42:11818\u201311830. https:\/\/doi.org\/10.1093\/nar\/gku861","journal-title":"Nucleic Acids Res"},{"key":"9923_CR65","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1093\/nar\/gkad548","volume":"51","author":"B Jin","year":"2023","unstructured":"Jin B, Zhu J, Pan T, Yang Y, Liang L, Zhou Y, Zhang T, Teng Y, Wang Z, Wang X, Tian Q, Guo B, Li H, Chen T (2023) MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation. Nucleic Acids Res 51:7951\u20137971. https:\/\/doi.org\/10.1093\/nar\/gkad548","journal-title":"Nucleic Acids Res"},{"key":"9923_CR66","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41580-022-00545-z","volume":"24","author":"LE Marasco","year":"2023","unstructured":"Marasco LE, Kornblihtt AR (2023) The physiology of alternative splicing. Nat Rev Mol Cell Biol 24:242\u2013254. https:\/\/doi.org\/10.1038\/s41580-022-00545-z","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9923_CR67","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41576-022-00556-8","volume":"24","author":"ME Rogalska","year":"2023","unstructured":"Rogalska ME, Vivori C, Valc\u00e1rcel J (2023) Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects. Nat Rev Genet 24:251\u2013269. https:\/\/doi.org\/10.1038\/s41576-022-00556-8","journal-title":"Nat Rev Genet"},{"key":"9923_CR68","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-1-0716-0327-7_17","volume":"2120","author":"J Racle","year":"2020","unstructured":"Racle J, Gfeller D (2020) EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data. Methods Mol Biol Clifton NJ 2120:233\u2013248. https:\/\/doi.org\/10.1007\/978-1-0716-0327-7_17","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"9923_CR69","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","volume":"128","author":"K Brummel","year":"2023","unstructured":"Brummel K, Eerkens AL, de Bruyn M, Nijman HW (2023) Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer 128:451\u2013458. https:\/\/doi.org\/10.1038\/s41416-022-02119-4","journal-title":"Br J Cancer"},{"key":"9923_CR70","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","volume":"184","author":"SX Lu","year":"2021","unstructured":"Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M, Knorr DA, Greenbaum B, Elhanati Y, Hogg SJ, Chow A, Ghosh A, Xie A, Zamarin D, Cui D, Erickson C, Singer M, Cho H, Wang E, Lu B, Durham BH, Shah H, Chowell D, Gabel AM, Shen Y, Liu J, Jin J, Rhodes MC, Taylor RE, Molina H, Wolchok JD, Merghoub T, Diaz LA, Abdel-Wahab O, Bradley RK (2021) Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell 184:4032\u20134047.e31. https:\/\/doi.org\/10.1016\/j.cell.2021.05.038","journal-title":"Cell"},{"key":"9923_CR71","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1210\/jc.2008-2564","volume":"94","author":"M Dur\u00e1n-Prado","year":"2009","unstructured":"Dur\u00e1n-Prado M, Gahete MD, Mart\u00ednez-Fuentes AJ, Luque RM, Quintero A, Webb SM, Benito-L\u00f3pez P, Leal A, Schulz S, Gracia-Navarro F, Malag\u00f3n MM, Casta\u00f1o JP (2009) Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J Clin Endocrinol Metab 94:2634\u20132643. https:\/\/doi.org\/10.1210\/jc.2008-2564","journal-title":"J Clin Endocrinol Metab"},{"key":"9923_CR72","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1210\/jc.2009-2247","volume":"95","author":"M Dur\u00e1n-Prado","year":"2010","unstructured":"Dur\u00e1n-Prado M, Saveanu A, Luque RM, Gahete MD, Gracia-Navarro F, Jaquet P, Dufour H, Malag\u00f3n MM, Culler MD, Barlier A, Casta\u00f1o JP (2010) A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs. J Clin Endocrinol Metab 95:2497\u20132502. https:\/\/doi.org\/10.1210\/jc.2009-2247","journal-title":"J Clin Endocrinol Metab"},{"key":"9923_CR73","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1038\/onc.2011.389","volume":"31","author":"M Dur\u00e1n-Prado","year":"2012","unstructured":"Dur\u00e1n-Prado M, Gahete MD, Hergueta-Redondo M, Mart\u00ednez-Fuentes AJ, C\u00f3rdoba-Chac\u00f3n J, Palacios J, Gracia-Navarro F, Moreno-Bueno G, Malag\u00f3n MM, Luque RM, Casta\u00f1o JP (2012) The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells. Oncogene 31:2049\u20132061. https:\/\/doi.org\/10.1038\/onc.2011.389","journal-title":"Oncogene"},{"key":"9923_CR74","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.canlet.2015.01.037","volume":"359","author":"RM Luque","year":"2015","unstructured":"Luque RM, Ib\u00e1\u00f1ez-Costa A, Neto LV, Taboada GF, Hormaechea-Agulla D, Kasuki L, Venegas-Moreno E, Moreno-Carazo A, G\u00e1lvez M\u00c1, Soto-Moreno A, Kineman RD, Culler MD, Gahete MD, Gadelha MR, Casta\u00f1o JP (2015) Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas. Cancer Lett 359:299\u2013306. https:\/\/doi.org\/10.1016\/j.canlet.2015.01.037","journal-title":"Cancer Lett"},{"key":"9923_CR75","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.18632\/oncotarget.6565","volume":"7","author":"M Sampedro-N\u00fa\u00f1ez","year":"2016","unstructured":"Sampedro-N\u00fa\u00f1ez M, Luque RM, Ramos-Levi AM, Gahete MD, Serrano-Somavilla A, Villa-Osaba A, Adrados M, Ib\u00e1\u00f1ez-Costa A, Mart\u00edn-P\u00e9rez E, Culler MD, Marazuela M, Casta\u00f1o JP (2016) Presence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors. Oncotarget 7:6593\u20136608. https:\/\/doi.org\/10.18632\/oncotarget.6565","journal-title":"Oncotarget"},{"key":"9923_CR76","doi-asserted-by":"publisher","first-page":"60110","DOI":"10.18632\/oncotarget.11076","volume":"7","author":"MD Gahete","year":"2016","unstructured":"Gahete MD, Rinc\u00f3n-Fern\u00e1ndez D, Dur\u00e1n-Prado M, Hergueta-Redondo M, Ib\u00e1\u00f1ez-Costa A, Rojo-Sebasti\u00e1n A, Gracia-Navarro F, Culler MD, Casanovas O, Moreno-Bueno G, Luque RM, Casta\u00f1o JP (2016) The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients. Oncotarget 7:60110\u201360122. https:\/\/doi.org\/10.18632\/oncotarget.11076","journal-title":"Oncotarget"},{"key":"9923_CR77","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1124\/pr.117.015388","volume":"70","author":"T G\u00fcnther","year":"2018","unstructured":"G\u00fcnther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp H-J, Lupp A, Korbonits M, Casta\u00f1o JP, Wester H-J, Culler M, Melmed S, Schulz S (2018) International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature. Pharmacol Rev 70:763\u2013835. https:\/\/doi.org\/10.1124\/pr.117.015388","journal-title":"Pharmacol Rev"},{"key":"9923_CR78","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13658","author":"E Alors-P\u00e9rez","year":"2024","unstructured":"Alors-P\u00e9rez E, Bl\u00e1zquez-Encinas R, Moreno-Montilla MT, Garc\u00eda-Vioque V, Jim\u00e9nez-Vacas JM, Mafficini A, Gonz\u00e1lez-Borja I, Luchini C, S\u00e1nchez-Hidalgo JM, S\u00e1nchez-Fr\u00edas ME, Pedraza-Arevalo S, Romero-Ruiz A, Lawlor RT, Vi\u00fadez A, Gahete MD, Scarpa A, Arjona-S\u00e1nchez \u00c1, Luque RM, Ib\u00e1\u00f1ez-Costa A, Casta\u00f1o JP (2024) Spliceosomic dysregulation in pancreatic cancer uncovers splicing factors PRPF8 and RBMX as novel candidate actionable targets. Mol Oncol. https:\/\/doi.org\/10.1002\/1878-0261.13658","journal-title":"Mol Oncol"},{"key":"9923_CR79","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/cancers11101439","volume":"11","author":"MC V\u00e1zquez-Borrego","year":"2019","unstructured":"V\u00e1zquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E, Rivero-Cort\u00e9s E, Dios E, Moreno-Moreno P, Madrazo-Atutxa A, Rem\u00f3n P, Solivera J, Wildemberg LE, Kasuki L, L\u00f3pez-Fern\u00e1ndez JM, Gadelha MR, G\u00e1lvez-Moreno MA, Soto-Moreno A, Gahete MD, Casta\u00f1o JP, Luque RM (2019) Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features. Cancers 11:1439. https:\/\/doi.org\/10.3390\/cancers11101439","journal-title":"Cancers"},{"key":"9923_CR80","doi-asserted-by":"publisher","first-page":"e1102","DOI":"10.1002\/ctm2.1102","volume":"12","author":"JL L\u00f3pez-C\u00e1novas","year":"2022","unstructured":"L\u00f3pez-C\u00e1novas JL, Herm\u00e1n-S\u00e1nchez N, Moreno-Montilla MT, Del Rio-Moreno M, Alors-Perez E, S\u00e1nchez-Frias ME, Amado V, Ciria R, Brice\u00f1o J, de la Mata M, Casta\u00f1o JP, Rodriguez-Per\u00e1lvarez M, Luque RM, Gahete MD (2022) Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing. Clin Transl Med 12:e1102. https:\/\/doi.org\/10.1002\/ctm2.1102","journal-title":"Clin Transl Med"},{"key":"9923_CR81","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.ebiom.2019.11.008","volume":"51","author":"JM Jim\u00e9nez-Vacas","year":"2020","unstructured":"Jim\u00e9nez-Vacas JM, Herrero-Aguayo V, Montero-Hidalgo AJ, G\u00f3mez-G\u00f3mez E, Fuentes-Fayos AC, Le\u00f3n-Gonz\u00e1lez AJ, S\u00e1ez-Mart\u00ednez P, Alors-P\u00e9rez E, Pedraza-Ar\u00e9valo S, Gonz\u00e1lez-Serrano T, Reyes O, Mart\u00ednez-L\u00f3pez A, S\u00e1nchez-S\u00e1nchez R, Ventura S, Yubero-Serrano EM, Requena-Tapia MJ, Casta\u00f1o JP, Gahete MD, Luque RM (2020) Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer. EBioMedicine 51:102547. https:\/\/doi.org\/10.1016\/j.ebiom.2019.11.008","journal-title":"EBioMedicine"},{"key":"9923_CR82","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1093\/brain\/awaa273","volume":"143","author":"AC Fuentes-Fayos","year":"2020","unstructured":"Fuentes-Fayos AC, V\u00e1zquez-Borrego MC, Jim\u00e9nez-Vacas JM, Bejarano L, Pedraza-Ar\u00e9valo S, L-L\u00f3pez F, Blanco-Acevedo C, S\u00e1nchez-S\u00e1nchez R, Reyes O, Ventura S, Solivera J, Breunig JJ, Blasco MA, Gahete MD, Casta\u00f1o JP, Luque RM (2020) Splicing machinery dysregulation drives glioblastoma development\/aggressiveness: oncogenic role of SRSF3. Brain J Neurol 143:3273\u20133293. https:\/\/doi.org\/10.1093\/brain\/awaa273","journal-title":"Brain J Neurol"},{"key":"9923_CR83","doi-asserted-by":"publisher","unstructured":"Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EGE, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, Lebwohl D, \u00d6berg K, RAD001 in Advanced Neuroendocrine Tumors, Third Trial (RADIANT-3) Study Group (2011) Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 364:514\u2013523. https:\/\/doi.org\/10.1056\/NEJMoa1009290","DOI":"10.1056\/NEJMoa1009290"},{"key":"9923_CR84","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bib\/bby047","volume":"20","author":"D Sulakhe","year":"2019","unstructured":"Sulakhe D, D\u2019Souza M, Wang S, Balasubramanian S, Athri P, Xie B, Canzar S, Agam G, Gilliam TC, Maltsev N (2019) Exploring the functional impact of alternative splicing on human protein isoforms using available annotation sources. Brief Bioinform 20:1754\u20131768. https:\/\/doi.org\/10.1093\/bib\/bby047","journal-title":"Brief Bioinform"},{"key":"9923_CR85","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/nar\/gkm1054","volume":"36","author":"F Birzele","year":"2008","unstructured":"Birzele F, Csaba G, Zimmer R (2008) Alternative splicing and protein structure evolution. Nucleic Acids Res 36:550\u2013558. https:\/\/doi.org\/10.1093\/nar\/gkm1054","journal-title":"Nucleic Acids Res"},{"key":"9923_CR86","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/s41594-023-01155-9","volume":"30","author":"P Kjer-Hansen","year":"2023","unstructured":"Kjer-Hansen P, Weatheritt RJ (2023) The function of alternative splicing in the proteome: rewiring protein interactomes to put old functions into new contexts. Nat Struct Mol Biol 30:1844\u20131856. https:\/\/doi.org\/10.1038\/s41594-023-01155-9","journal-title":"Nat Struct Mol Biol"},{"key":"9923_CR87","doi-asserted-by":"publisher","first-page":"eabn9232","DOI":"10.1126\/sciadv.abn9232","volume":"8","author":"S Zhang","year":"2022","unstructured":"Zhang S, Mao M, Lv Y, Yang Y, He W, Song Y, Wang Y, Yang Y, Al Abo M, Freedman JA, Patierno SR, Wang Y, Wang Z (2022) A widespread length-dependent splicing dysregulation in cancer. Sci Adv 8:eabn9232. https:\/\/doi.org\/10.1126\/sciadv.abn9232","journal-title":"Sci Adv"},{"key":"9923_CR88","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-022-00481-2","volume":"22","author":"K Tan","year":"2022","unstructured":"Tan K, Stupack DG, Wilkinson MF (2022) Nonsense-mediated RNA decay: an emerging modulator of malignancy. Nat Rev Cancer 22:437\u2013451. https:\/\/doi.org\/10.1038\/s41568-022-00481-2","journal-title":"Nat Rev Cancer"},{"key":"9923_CR89","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.tig.2020.11.002","volume":"37","author":"F Supek","year":"2021","unstructured":"Supek F, Lehner B, Lindeboom RGH (2021) To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases. Trends Genet TIG 37:657\u2013668. https:\/\/doi.org\/10.1016\/j.tig.2020.11.002","journal-title":"Trends Genet TIG"},{"key":"9923_CR90","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1158\/0008-5472.CAN-21-4367","volume":"82","author":"J Tian","year":"2022","unstructured":"Tian J, Chen C, Rao M, Zhang M, Lu Z, Cai Y, Ying P, Li B, Wang H, Wang L, Li Y, Huang J, Fan L, Cai X, Ning C, Li Y, Zhang F, Wang W, Jiang Y, Liu Y, Wang M, Li H, Huang C, Yang Z, Chang J, Zhu Y, Yang X, Miao X (2022) Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk. Cancer Res 82:2084\u20132096. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-4367","journal-title":"Cancer Res"},{"key":"9923_CR91","doi-asserted-by":"publisher","unstructured":"Urbanski L, Brugiolo M, Park S, Angarola BL, Leclair NK, Yurieva M, Palmer P, Sahu SK, Anczuk\u00f3w O (2022) MYC regulates a pan-cancer network of co-expressed oncogenic splicing factors. Cell Rep 41:. https:\/\/doi.org\/10.1016\/j.celrep.2022.111704","DOI":"10.1016\/j.celrep.2022.111704"},{"key":"9923_CR92","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12576-019-00689-2","volume":"69","author":"Y Yang","year":"2019","unstructured":"Yang Y, Zhang B, Nakata M, Nakae J, Mori M, Yada T (2019) Islet \u03b2-cell-produced NUCB2\/nesfatin-1 maintains insulin secretion and glycemia along with suppressing UCP-2 in \u03b2-cells. J Physiol Sci JPS 69:733\u2013739. https:\/\/doi.org\/10.1007\/s12576-019-00689-2","journal-title":"J Physiol Sci JPS"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-026-09923-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12022-026-09923-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-026-09923-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:09:07Z","timestamp":1783573747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12022-026-09923-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":92,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["9923"],"URL":"https:\/\/doi.org\/10.1007\/s12022-026-09923-1","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient samples and data were collected by the ARC-Net Research Centre biobank, University of Verona, Italy, under Prog. 1885 (Prot. N. 52070) from the Integrated University Hospital Trust Ethics Committee (AUOI-CE) and used in this study under protocol CE2172 (Prot. N. 26773). The procedures were performed in accordance with the Helsinki Declaration and every patient signed an informed consent document.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Where authors are identified as personnel of the International Agency for Research on Cancer\/WHO, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy, or views of the International Agency for Research on Cancer\/WHO.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}